Tirzepatide (Mounjaro®) is a new medication for the treatment of type II diabetes with a dual acting mechanism acting as a GLP/GIP agonist. This episode discusses the new mechanism of action, some of the trial info that led to its approval, and its current place in therapy for diabetes management.

• Marcus Pribyl, PharmD. Current role as of 6/26/23: PGY1 Pharmacy Resident at SSM Health Monroe Clinic. After I am starting a new role at Olympia Medical Center as an Ambulatory Care Clinical Pharmacist.
• Miaja Anderson, PharmD. Current role as of 6/26/23: PGY1 Pharmacy Resident at SSM Health Monroe Clinic. After, Maija is starting a new role at Monroe Hospital as an Inpatient Pharmacist.